Duchenne muscular dystrophy (DMD) is the most common form of muscular dystrophy and is among the most common human genetic diseases. A variety of mini- and full-length dystrophin cassettes can prevent the development of most or all dystrophic symptoms in mdx mice, a model for DMD. These cassettes can be delivered efficiently to adult mdx mouse muscles using several viral vectors, including gutted adenovirus (Ad) or adeno-associated virus (AAV), resulting in a reversal of many dystrophic features. Nonetheless, a major rate limiting step for DMD gene therapy is the ability to target muscles throughout the body. Considerable interest has developed in the use of stem cells, such as hematopoietic and mesenchymal stem cells, to contribute systemically to the repair of muscle tissue. However, transplantation of normal donor cells into a patient entails substantial risks of immune rejection and graft vs. host disease. Performing autologous stem cell transplantation after transduction with an integrating dystrophin expression vector could ameliorate this risk. We propose to develop a variety of lentiviral vectors and explore their ability to transduce bone marrow cells and myogenic precursors. Lentiviral vectors have a 9 kb cloning capacity and can hold both micro- and mini-dystrophins, together with muscle-specific promoters. Lentiviral vectors also integrate into the host cell genome leading to permanent expression for the lifetime of the targeted cell. We will test and compare the ability of these vectors to transduce stem cells and muscle precursors, and to deliver functional dystrophin to muscle following either ex vivo or in vivo gene transfer. We will also explore gene transfer methods to stimulate conversion of non-muscle cells to myogenic stem cells and/or satellite cells, and to drive expansion of myogenic precursors in muscle tissue. Together, these studies will increase the prospects of using stem cell technologies for DMD gene therapy. If successful, these methods could be applied to many different types of muscular dystrophy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
5P01NS046788-05
Application #
7582230
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
Project End
Budget Start
2008-04-01
Budget End
2009-03-31
Support Year
5
Fiscal Year
2008
Total Cost
$610,728
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Whitehead, Nicholas P; Kim, Min Jeong; Bible, Kenneth L et al. (2015) A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy. Proc Natl Acad Sci U S A 112:12864-9
Muir, Lindsey A; Nguyen, Quynh G; Hauschka, Stephen D et al. (2014) Engraftment potential of dermal fibroblasts following in vivo myogenic conversion in immunocompetent dystrophic skeletal muscle. Mol Ther Methods Clin Dev 1:14025
Parker, Maura H; Tapscott, Stephen J (2013) Expanding donor muscle-derived cells for transplantation. Curr Protoc Stem Cell Biol Chapter 2:Unit 2C.4
Gantz, Jay A; Palpant, Nathan J; Welikson, Robert E et al. (2012) Targeted genomic integration of a selectable floxed dual fluorescence reporter in human embryonic stem cells. PLoS One 7:e46971
Parker, Maura H; Loretz, Carol; Tyler, Ashlee E et al. (2012) Activation of Notch signaling during ex vivo expansion maintains donor muscle cell engraftment. Stem Cells 30:2212-20
Himeda, Charis L; Tai, Phillip W L; Hauschka, Stephen D (2012) Analysis of muscle gene transcription in cultured skeletal muscle cells. Methods Mol Biol 798:425-43
Johnson, Eric K; Zhang, Liwen; Adams, Marvin E et al. (2012) Proteomic analysis reveals new cardiac-specific dystrophin-associated proteins. PLoS One 7:e43515
Tai, Phillip W L; Smith, Catherine L; Angello, John C et al. (2012) Analysis of fiber-type differences in reporter gene expression of ?-gal transgenic muscle. Methods Mol Biol 798:445-59
Suga, Tomohiro; Kimura, En; Morioka, Yuka et al. (2011) Muscle fiber type-predominant promoter activity in lentiviral-mediated transgenic mouse. PLoS One 6:e16908
Gonçalves, Manuel A F V; Janssen, Josephine M; Nguyen, Quynh G et al. (2011) Transcription factor rational design improves directed differentiation of human mesenchymal stem cells into skeletal myocytes. Mol Ther 19:1331-41

Showing the most recent 10 out of 32 publications